42 related articles for article (PubMed ID: 9093712)
21. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
Papadimitrakopoulou VA; Lee JJ; William WN; Martin JW; Thomas M; Kim ES; Khuri FR; Shin DM; Feng L; Hong WK; Lippman SM
J Clin Oncol; 2009 Feb; 27(4):599-604. PubMed ID: 19075276
[TBL] [Abstract][Full Text] [Related]
22. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
Papadimitrakopoulou VA; Clayman GL; Shin DM; Myers JN; Gillenwater AM; Goepfert H; El-Naggar AK; Lewin JS; Lippman SM; Hong WK
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1083-9. PubMed ID: 10522499
[TBL] [Abstract][Full Text] [Related]
23. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
24. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
[TBL] [Abstract][Full Text] [Related]
25. Retinoid chemoprevention of second primary tumors.
Benner SE; Lippman SM; Hong WK
Semin Hematol; 1994 Oct; 31(4 Suppl 5):26-30. PubMed ID: 7831582
[TBL] [Abstract][Full Text] [Related]
26. Results, toxicity and compliance in chemoprevention trials of head and neck cancer.
Toma S; Palumbo R; Rosso R
Eur J Cancer Prev; 1994 Jan; 3(1):63-8. PubMed ID: 8130719
[TBL] [Abstract][Full Text] [Related]
27. Moving toward bioadjuvant approaches to head and neck cancer prevention.
Saba NF; Hammond A; Shin DM; Khuri FR
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S132-5. PubMed ID: 17848282
[TBL] [Abstract][Full Text] [Related]
28. Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.
Moreno L; DuBois SG; Glade Bender J; Mauguen A; Bird N; Buenger V; Casanova M; Doz F; Fox E; Gore L; Hawkins DS; Izraeli S; Jones DTW; Kearns PR; Molenaar JJ; Nysom K; Pfister S; Reaman G; Smith M; Weigel B; Vassal G; Zwaan CM; Paoletti X; Iasonos A; Pearson ADJ
J Clin Oncol; 2023 Jun; 41(18):3408-3422. PubMed ID: 37015036
[TBL] [Abstract][Full Text] [Related]
29. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity.
Dimery IW; Hong WK; Lee JJ; Guillory-Perez C; Pham F; Fritsche HA; Lippman SM
Ann Oncol; 1997 Jan; 8(1):85-9. PubMed ID: 9093712
[TBL] [Abstract][Full Text] [Related]
30. Retinoids and chemoprevention: clinical and basic studies.
Lippman SM; Heyman RA; Kurie JM; Benner SE; Hong WK
J Cell Biochem Suppl; 1995; 22():1-10. PubMed ID: 8538183
[TBL] [Abstract][Full Text] [Related]
31. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
